New Risk • Jun 05
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: CA$137.5m (US$98.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 92% per year over the past 5 years. Shareholders have been substantially diluted in the past year (80% increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (CA$137.5m market cap, or US$98.7m). Announcement • Jun 03
Apex Critical Metals Corp. announced that it has received CAD 15.0005 million in funding On June 2, 2026, Apex Critical Metals Corp. closed the transaction. The units were offered in each of the provinces and territories of Canada, except Québec; in the United States and in such other jurisdictions outside of Canada and the United States. Certain insiders of the company participated in the offering. Announcement • May 20
Apex Critical Metals Corp. announced that it expects to receive CAD 10.0016 million in funding Apex Critical Metals Corp. has announced that it has entered into an agreement with Canaccord Genuity Corp. to act as lead agent and sole bookrunner along with a syndicate of agents to be formed in connection with a best efforts private placement of up to 5,264,000 units of the Company at a price of CAD 1.90 per Unit for aggregate gross proceeds of up to CAD 10,001,600 on May 18, 2026. Each Unit will consist of one common share of the Company and one Common Share purchase warrant of the Company. Each Warrant will be exercisable to acquire one Common Share at a price of CAD 2.60 per Warrant Share for a period of 24 months from the Closing Date. The Warrants to be issued pursuant to the Offering will not be listed for trading on any stock exchange. The Offering is expected to close on or about June 2, 2026 or such other date as determined by the Company and the Agents, such date being no later than 45 days from the date hereof. The Company will grant the Agents an option to sell up to 789,600 additional Units at the Offering Price for additional gross proceeds of up to CAD 1,500,240. The Agents Option shall be exercisable at any time up to 48 hours prior to the Closing Date. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 Prospectus Exemptions (NI 45-106), the Offering is being made to purchasers resident in all provinces and territories of Canada, except Qubec, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the Listed Issuer Financing Exemption). The Units to be offered under the Listed Issuer Financing Exemption will not be subject to a hold period in Canada in accordance with applicable Canadian securities laws. As consideration for their services in connection with the Offering, the Agents will receive a cash commission equal to 6% of the gross proceeds of the Offering and compensation warrants equal to 3% of the aggregate number of Units sold under the Offering with each Compensation Warrant exercisable to purchase one Common Share at CAD 1.90 for a period of 24 months from the Closing Date. In each case, the consideration will be reduced to 3% in the case of Presidents List investors. Any sale of Units to persons in the United States will be made to 'Accredited Investors' pursuant to Rule 506(b) of Regulation D. 
